scholarly journals Age and gender differences in health-related quality of life of children and adolescents in Europe: a multilevel analysis

2009 ◽  
Vol 18 (9) ◽  
pp. 1147-1157 ◽  
Author(s):  
Gisela Michel ◽  
◽  
Corinna Bisegger ◽  
Daniela C. Fuhr ◽  
Thomas Abel
2020 ◽  
Vol 32 (10) ◽  
pp. 2041-2047
Author(s):  
Anna K. Ojala ◽  
Harri Sintonen ◽  
Risto P. Roine ◽  
Timo E. Strandberg ◽  
Camilla Schalin-Jäntti

Abstract Background Cardiovascular disease (CVD) and thyroid dysfunction are common in older people, but little is known about how they affect health-related quality of life (HRQoL). Methods We assessed HRQoL with the 15D instrument in 329 home-dwelling patients aged ≥ 75 years with stable CVD and compared the results to those of an age- and gender-matched general population (n = 103). We also studied the impact of age, BMI, number of medications, thyroid-stimulating hormone (TSH) concentration, levothyroxine (L-T4) substitution and Mini-Mental State Examination (MMSE) on HRQoL. Results Overall HRQoL was impaired in older people with stable CVD (mean 15D score 0.777 vs 0.801, p = 0.001), and also on single dimensions of breathing, sleeping, discomfort and symptoms, distress, vitality (all p < 0.001), and depression (p = 0.016) compared to the age- and gender-matched general population. Furthermore, in the patients, L-T4 substitution associated with impaired sleeping (p = 0.018) and sexual activity (p = 0.030). Moreover, MMSE points, number of medications used, age (all p < 0.001) and BMI (p = 0.009) predicted impaired HRQoL. Conclusions Older people with stable CVD are characterized by impaired HRQoL compared to age- and gender-matched controls. We demonstrate that this is the consequence of impaired breathing, sleeping, discomfort and symptoms, distress, vitality, and depression. L-T4 substitution has a negative impact on HRQoL in old patients with stable CVD. MMSE score, number of medications, age and BMI predict worse HRQoL.


Sign in / Sign up

Export Citation Format

Share Document